As of 2025-07-07, the Fair Value of Creo Medical Group PLC (CREO.L) is -25.18 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 12.75 GBP, the upside of Creo Medical Group PLC is -297.48%.
With the market price of 12.75 GBP and our fair value calculation, Creo Medical Group PLC (CREO.L) is not a good investment. Investing in CREO.L stocks now will result in a potential loss of 297.48%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -20.32 | -24.59 | -26.94 | -21.70 | -28.70 | -24.45 |
| YoY growth | -27.68% | -21.06% | -9.52% | 19.44% | -32.26% | -14.22% |
| Market Cap (mil) | 56.72 |
| P/E | |
| Forward P/E |
| EPS | -5.04 |
| Avg earnings growth rate | -14.22% |
| TTM earnings | -22.40 |